Targeting splicing-derived neoantigens for precision cancer immunotherapy.

Tang M, Grimes HL, Salomonis N.

Open source

DOI: 10.3389/fimmu.2026.1900283
Published: 2026-08-27
Container: Front Immunol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1900283,
  title = {Targeting splicing-derived neoantigens for precision cancer immunotherapy.},
  author = {Tang M and  Grimes HL and  Salomonis N.},
  year = {2026},
  journal = {Front Immunol},
  doi = {10.3389/fimmu.2026.1900283},
  url = {https://doi.org/10.3389/fimmu.2026.1900283}
}

RIS

TY  - JOUR
TI  - Targeting splicing-derived neoantigens for precision cancer immunotherapy.
AU  - Tang M
AU  -  Grimes HL
AU  -  Salomonis N.
PY  - 2026
JO  - Front Immunol
DO  - 10.3389/fimmu.2026.1900283
UR  - https://doi.org/10.3389/fimmu.2026.1900283
ER  -

APA

M, T., HL, G., & N., S. (2026). Targeting splicing-derived neoantigens for precision cancer immunotherapy.. Front Immunol. https://doi.org/10.3389/fimmu.2026.1900283

Source records

europe-pmc · retrieved 2026-09-25T07:01:25.492Z
doaj · retrieved 2026-09-25T07:01:25.499Z